Anti-nucleaire ANA screening auto-immuunziekte

  1. Een positieve ANA uitslag komt voor bij verschillende ziekten in%: SLE: Actief: 95-100%; SLE niet actief: 80-100%; Lupes door medijnen: 95%; Systemische sclerose: 85-95%; Poly / dermatomyositis: 30-50%; Het syndroom van Sj en oumlgren: 70-80%; Reumato en iumlde artritis: 20-40%; Chronische actieve hepatitis: 20-40
  2. The antinuclear antibodies (ANA) also known as antinuclear factors (ANF) are unwanted molecules which bind and destroy certain structures within the nucleus. In systemic lupus erythematosus (SLE), they are produced in excess; hence their detection in the blood of patients is important for diagnosis and monitoring of the disease
  3. Bij SLE gaat het vooral om antistoffen die zich richten tegen onderdelen van de kern van de lichaamscellen. Een algemene naam voor deze antistoffen is ANA: antinucleaire antistoffen of ANF: antinucleaire factor (nucleair = tot de kern behorend). Als deze antistoffen in het bloed aanwezig zijn, dan is er een positieve ANA-test of positieve ANF-test
  4. Bij Systemische lupus erythematodes (SLE) komt een positieve ANA met een titer van >= 1:640 bij vrijwel alle patiënten voor. Er zijn echter ook andere auto-immuun aandoeningen waarbij de titer verhoogd kan zijn. Aantoonbare antinucleaire antistoffen kunnen een aanwijzing zijn voor auto-immuunziekten. Niet van toepassing
  5. Bij Systemische lupus erythematodes (SLE) komt een positieve ANA met een titer van ≥ 1:640 bij vrijwel alle patiënten voor. Maar ook bij andere auto-immuunziektes komen positieve ANA vaker voor: systemische sclerose , Syndroom van Sjögren , dermatomyositis , mixed connective tissue disease
  6. Systemische lupus (SLE) SLE is een auto-immuunziekte. Dat houdt in dat het afweersysteem zich tegen lichaamseigen bestanddelen richt en ontstekingsverschijnselen veroorzaakt. Deze ontstekingsverschijnselen kunnen overal in het lichaam voorkomen en schade aanrichten aan de huid, bloedvaten en organen. De teksten over systemische lupus zijn gebaseerd.

De diagnose wordt bevestigd door een biopt. Serologisch onderzoek naar SLE is bij een CDLE patiënt niet zinvol. Bij een deel (circa 20%) van de patiënten is de ANA (antinuclear antibody) positief, maar dat komt ook bij gezonden vaak voor. Er wordt dus geen consequentie aan dit onderzoek verbonden, daarom niet aanvragen Om de diagnose SLE te stellen moet de patiënt achtereenvolgens of tegelijkertijd aan tenminste 4 criteria voldoen. Ook kan de diagnose SLE gesteld worden als er sprake is van nierontsteking passend bij lupus (bewezen met een nierbiopsie) in aanwezigheid van ANA of anti-ds-DNA De reumatische aandoeningen die mede gekenmerkt worden door de aanwezigheid van ANA zijn RA en de groep van zogenoemde bindweefselziekten, zoals SLE, primair Sjögren-syndroom en sclerodermie In simplest terms, ANA-negative lupus is a condition in which a person's ANA (antinuclear antibody) immunofluorescence (IF) test comes back negative, but the person exhibits traits consistent with someone diagnosed with systemic lupus erythematosus (SLE; also called lupus). The ANA IF test is an important tool in diagnosing lupus

Standard laboratory tests for SLE. Antinuclear antibody (ANA) autoantibodies, or antibodies produced by the immune system that attack the body's own cells, are a hallmark of lupus. ANA is a screening test, since almost all patients with lupus have a strongly positive test Anti-nRNP/anti-U1-RNP. Anti-nuclear ribonucleoprotein (anti-nRNP) antibodies, also known as anti-U1-RNP antibodies, are found in 30-40% of SLE. They are often found with anti-Sm antibodies, but they may be associated with different clinical associations

Detection of antinuclear antibodies in SL

Abstract. This study aimed to directly analyze the potential relationship of anti-nuclear antibodies (ANA) before and after the administration of TNF-α inhibitors (TNFi) with the appearance of anti-drug antibodies (ADrA) in patients with rheumatoid arthritis (RA). A total of 121 cases, viz., 38, 53, and 30 cases treated with infliximab (IFX),. ANA wordt in het bloed van bijna elke SLE patiënt gevonden. Een positieve ANA test is echter op zich geen bewijs voor het bestaan van SLE, omdat de test ook positief kan zijn bij andere ziekten en zelfs zwakpositief kan zijn bij ongeveer 5 procent van de gezonde kinderen

Lupus erythematosus, vaak afgekort als LE of SLE (systemische lupus erythematosus), soms ook wel systemische lupus erythematodes genoemd, is een auto-immuunziekte, waarbij het eigen afweersysteem ontregelt is en het afweersysteem zich tegen het eigen lichaam keert. Bij SLE kunnen overal in het lichaam klachten ontstaan, vandaar dat het ook wel. Anti-nucleaire antilichamen (ANA) In het bloed van bijna elke SLE-patiënt worden anti-nucleaire antilichamen (ANA) gevonden. Een positieve ANA-test is echter op zich geen bewijs voor het bestaan van SLE, aangezien de test ook positief kan zijn bij andere ziekten en zelfs zwakpositief kan zijn bij ongeveer 5 procent van de gezonde kinderen part of the antibodies detected by ANA, and are tested commonly in SLE. They are more specific to SLE (97% specificity), but much lower in sensitivity (60%). 1 ANA and anti-dsDNA are two of the 11 criteria for the classification of SLE. 10 The prevalence of ANA and anti-dsDNA varies among autoimmune diseases, depending on th Antinuclear antibody (ANA) testing and anti-extractable nuclear antigen form the mainstay of serologic testing for SLE. If ANA is negative the disease can be ruled out. Several techniques are used to detect ANAs. The most widely used is indirect immunofluorescence (IF)

Antistoffen - Nationale vereniging voor lupus, APS

  1. Abstract. Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue.
  2. atus (LED) is een auto-immuunziekte, met symptomen in allerlei organen.Het wordt onderscheiden van andere varianten van lupus erythematodes die meestal tot de huid beperkt blijven. De ziekte verloopt of afwisselend tussen periodes van opvlam
  3. ANA may be detected in several disorders, including: Systemic lupus erythematosus; Sjögren's syndrome; Polymyositis and dermatomyositis; Juvenile idiopathic arthritis; Raynaud's phenomenon; Drug-induced lupus; Mixed connective tissue disease; Autoimmune hepatitis; ANA testing cannot diagnose an autoimmune disorder on its own
  4. The recent publication1 2 of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) criteria for the classification for systemic lupus erythematosus (SLE) provides an important reason to continue the dialogue on testing for antinuclear antibodies (ANA) that has appeared in Annals of the Rheumatic Diseases ( ARD )
  5. Objective Antinuclear antibody (ANA) analysis by immunofluorescence (IF) microscopy remains a diagnostic hallmark of systemic lupus erythematosus (SLE). The clinical relevance of ANA fine-specificities in SLE has been addressed repeatedly, whereas studies on IF-ANA staining patterns in relation to disease manifestations are very scarce. This study was performed to elucidate whether different.

SLE affects almost every organ system, with differing degrees of severity. During its clinical course periods of flares may alternate with periods of remission culminating in disease and therapy related damage. We describe a case of ANA negative SLE with severe thrombocytopenia, cutaneous vasculitis, antiphospholipid antibody syndrome, and pulmonary artery hypertension Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue. ANA dsDNA ENA C3, C4 Urinary protein Creatinine ESR CRP 8 8 4 4 4 4 4 8 Table 3. Main Disease Associations with dsDNA and ENAs Anti dsDNA Specific for SLE Anti SSA / Ro SLE, Sjogrens Syndrome (The babies of pregnant women with anti SSA are at risk of neonatal heartblock) Anti SSB / La SLE, Sjogrens Syndrome Anti RNP SLE/Mixed Connective Tissue.

SLE op grond van de criteria: vlindervormige huiduitslag, ulcus op wangslijmvlies, gevoelig voor zonlicht, ANA positief, anti-dsDNA, BSE is verhoogd en dat past ook bij SLE, leuko's zijn verlaagd. Presentatie deze labwaarden uitzoeken An ANA titer of less than 1:40 is useful for ruling out SLE in children (sensitivity of 98%). A repeated negative result makes a diagnosis of SLE unlikely but not impossible. The ANA titer does.

Antinucleaire antistoffen Labuitslag

Antinucleaire antistof - Wikipedi

ANA substrate. Sera of some patients with SLE may be negative on animal substrates i.e. mouse kidney or rat liver but are positive on human substrate i.e. Hep-2 cell lines [26-28]. Due to variable sensitivity with the substrate used it is essential to report the type of substrate being used by the lab Other ANA that may occur in people with SLE are anti-U1 RNP (which also appears in systemic sclerosis and mixed connective tissue disease), SS-A (or anti-Ro) and SS-B (or anti-La; both of which are more common in Sjögren's syndrome). SS-A and SS-B confer a specific risk for heart conduction block in neonatal lupus Systemic lupus erythematosus (SLE), is the most common type of lupus. SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels Introduction. The classification criteria for lupus acknowledge just two central nervous system (CNS) features, psychosis and seizures [1, 2].In reality, however, SLE may cause a wide range of neurological and psychiatric symptoms including those due to central, peripheral and autonomic nervous system and different psychiatric syndromes

Systemische lupus (SLE) - Nationale vereniging voor lupus

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with highly variable clinical and immunological manifestations. In the classification of patients with this condition, the presence of an antinuclear antibody (ANA) is an important element, with new criteria from the American College of Rheumatology and European League against Rheumatism positioning ANA positivity by an. The SLICC criteria for SLE classification requires: 1) Fulfillment of at least four criteria, with at least one clinical criterion AND one immunologic criterion OR 2) Lupus nephritis as the sole clinical criterion in the presence of ANA or anti-dsDNA antibodies. Clinical Criteria: 1. Acute cutaneous lupus. 2 Uncommon Findings: A number of distinct clinical syndromes are seen in patients with SLE. —Drug-induced lupus: Patients treated with some medications may develop signs and symptoms of SLE. Drug-induced lupus is also associated with development of positive ANA, particularly with reactivity to histones. Indeed, the utility of a positive ANA cannot be determined in drug-induced lupus as a. Ook kan de diagnose SLE gesteld worden als er sprake is van nierontsteking passend bij lupus (bewezen met een nierbiopsie) in aanwezigheid van ANA of anti‐ds‐DNA. Onderzoeken bij SLE Laboratoriumonderzoek levert een bijdrage om de diagnose SLE te stellen en kan aantonen welke inwendige organen eventueel aangedaan zijn

Lupus erythematodes (lupus erythematosus, LE, SLE

The fluorescent test for ANA is the best initial test for SLE in patients who have compatible symptoms and signs; positive ANA tests (usually in high titer: > 1:80) occur in > 98% of people with SLE. However, positive ANA tests can also occur in rheumatoid arthritis, other connective tissue disorders, autoimmune thyroid disease, cancers, and even in the general population Tes ANA pada Penyakit Lupus dan Autoimun Lainnya. Tes ANA atau antinuclear antibody merupakan salah satu pemeriksaan yang sering dipakai untuk menunjang diagnosis penyakit lupus atau SLE (systemic lupus erythematosus). Terkadang sering kali pasien datang membawa hasil pemeriksaan ANA yang positif 1 SLE patient met three criteria (renal disorder, positive ANA, and immunological disorder). values for 2-group comparisons were calculated using Student's -test for continuous variables and Fisher's exact test or chi-squared test for categorical variables, while values for 3-group comparisons were calculated using one-way ANOVA for continuous variables and Fisher's exact test or chi. Positive ANA is required for SLE classification and ANA remains an appropriate screening test. While SLE manifestations are extremely variable, the 24 items in 10 domains will classify most patients. For classification and diagnosis, symptoms should only count when there is no more likely alternative explanation Thus an ANA-negative person with strongly positive antibody to Sm is said to have lupus. Because laboratories vary in how they report and (to be efficient) this writer, when evaluating a new patient for lupus, simultaneously tests for ANA, anti-DNA, anti-Sm, anti-Ro/SSA, anti-La/SSB, anti-RNP, and sometimes other antibodies that may be.

While ANA testing has high sensitivity for SLE and can be useful in early diagnosis, ANA specificity is low due to its presence in numerous other patient groups, including patients with other autoimmune diseases as well as infectious and malignant diseases. 7 ANA positivity is also encountered in healthy individuals — for example, up to 23% of patients over the age of 85, according to one. Antihistone antibodies are nearly always present in patients with drug-induced SLE. If antihistone antibodies are not detected, then the likelihood of this diagnosis (drug-induced SLE) is greatly reduced. A WORD OF CAUTION. A positive test for antinuclear antibodies (ANA) does not, by itself, indicate the presence of an autoimmune disease ANA-negative SLE has decreased [12,14]. Another cause of ANA-negative findings is that ANA is present, but its ' bound in the form of immune complexes A positive ANA titer (> 1:80) with the associated clinical signs (e.g. skin disease, polyarthritis) and laboratory findings (e.g. proteinuria, thrombocytopenia) is diagnostic for SLE. ANA tests are used to support a diagnosis of SLE, but it must be realized that positive results can be seen in a variety of conditions, other than SLE, including infectious and non-immune-mediated inflammatory.

Anti-dsDNA antibodies - YouTube

Background/Purpose: Anti-nuclear antibodies (ANA) are important biomarkers for the diagnosis and classification of systemic lupus erythematosus (SLE). However, emerging data from cross-sectional studies suggest variation in the performance between ANA assays. The purpose of this project was to compare the performance of three different ANA assays in a longitudinal analysis of samples from the. My ANA was tested at my own prompting after researching all my symptoms on the Internet. I guess my questions are: 1) Are there any more tests to determine if I have one disorder as opposed to the other? 2) Is it a good idea to just wait and see what symptoms I develop over time in the event that I do have Scleroderma or SLE

Systemische lupus erythematodes - PRINT

Så vil kun hver 50. med positiv ANA have SLE Incidens ANA-associeret CTD: 500 (2300) / år, 15% har muskulo-skeletale problemer RM: 1.300.000 indbyggere 52 nye SLE / år Der udføres 20.000 ANA / år 47 sandt positive (= SLE) 800 'falsk' positive (= non-ANA associeret sygdom/raske)) EliA CTD Scree An ANA test is used to help diagnose autoimmune disorders, including: Systemic lupus erythematosus (SLE). This is the most common type of lupus, a chronic disease affecting multiple parts of the body, including the joints, blood vessels, kidneys, and brain. Rheumatoid arthritis, a condition that causes pain and swelling of the joints, mostly in. most patients with SLE have positive ANA test results, most patients with positive ANA results do not have SLE. If results show a 1:40 titer or higher, more specifi erythematosus (SLE) • ANA sensitivity 93%, specificity 57% • Best initial test when clinical suspicion of SLE is strong • SLE unlikely if ANA negativ

De klinische betekenis van het aantonen van

ANA-Negative Lupus Symptoms and Tests - Verywell Healt

It is cases such as these that have piqued the interest of rheumatologists in the ANA and its role in SLE. The patient in case 1 has no end organ involvement of her lupus, yet her ANA titer is > 1:1280. In contrast, the patent in case 2 has multi-organ involvement of SLE, with a low positive ANA titer at 1:80. Advertising Policy Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, with multisystemic involvement. The disease has several phenotypes, with varying clinical presentations in patients ranging from mild mucocutaneous manifestations to multiorgan and severe central nervous system involvement. Several immunopathogenic pathways play a role in the development of SLE ANA zijn aanwezig bij heel veel verschillende soorten auto-immuunziekten, anti-ds-DNA komt vrijwel alleen voor bij systemische lupus erythematodus (SLE). Wat meten we en waarom? De test bepaalt de aan- of afwezigheid van antinucleaire antistoffen (ANA) en anti-dsDNA About 95% of patients with SLE have a positive ANA test result. If a patient has symptoms of SLE, such as arthritis, a rash, and autoimmune thrombocytopenia (a low number of specialised blood cells called platelets), then they may have SLE. In such cases, a positive ANA result can be useful to support SLE diagnosis

Understanding Lupus Lab Tests and Results Rheumatolog

Once SLE is suspected, the initial evaluation should include an antinuclear antibody (ANA) test. 15 This is a highly sensitive test, with positive results in about 94% of patients with SLE. 15 SLE is unlikely in a patient Table 1. Differential Diagnosis of Systemic Lupus Erythematosus Differential diagnosis Distinguishing features Diagnostic. • ANA substrate: • Sera of some patients with SLE may be negative on animal substrates i.e. mouse kidney or rat liver but are positive on human substrate i.e. Hep-2 cell lines. • Due to variable sensitivity with the substrate used it is essential to report the type of substrate being used by the lab Testen ANCA. De ANCA -test wordt gebruikt bij de diagnose van vasculitis. Ze wordt ook gebruikt om te controleren of de behandeling aanslaat en om nieuwe opvlammingen te signaleren. ANCA komen alleen voor bij GPA, MPA en EGPA en niet bij de andere vormen van vasculitis. Daarom spreekt men bij deze drie over ANCA geassocieerde vasculitis Uit de getallen blijkt dat ANA-onderzoek relatief vaak (35) wordt herhaald. In dit artikel willen wij nader ingaan op het belang van het verrichten van onderzoek naar de aanwezigheid van een van de bekendste ANA's, de antistoffen tegen dubbelstrengs DNA (anti-dsDNA) Autoantibodies in SLE Antibody Prevalence Antigen recognized ANA 98 % Multiple nuclear antigens Anti-dsDNA 70 Double stranded DNA Anti-Sm 25 Protein complexed to 6 species of nuclear U1 RNA Anti-RNP 40 Protein complexed to U1 RNA Anti-Ro (SS-A) 30 Protein complexed to hY RNA (60kDa and 52 kDa) Anti-La (SS-B) 10 Protein complexed to hyRNA (47 -kDa) Antihistone 70 Histone proteins associated.

Normal Results ANA is reported as a titer. Low titers are in the range of 1:40 to 1:60. A positive ANA test is of much more importance if you also have antibodies against the double-stranded form of DNA. The presence of ANA does not confirm a diagnosis of systemic lupus erythematosus (SLE) ANA pattern [10]. Our retrospective study included 425 patients from our university . Table 2: Prevalence of SARD diseases in ANA-DFS positive patients by titer a,b. Titer . health care system with a positive ANA-DFS pattern consecutively from August 2017 to September 2018. Patient sera underwent ANA SLE (systemic lupus erythematosus) — antinuclear antibody (ANA) are most commonly seen with SLE. About 95% of those with SLE have a positive ANA test result. If someone also has symptoms of SLE, such as arthritis, a rash, and skin sensitivity to light, then the person probably has SLE

A positive ANA test does not mean that a person has lupus. The physician needs to find other clinical features such as butterfly rashes, arthritis, pleurisy, blood abnormalities, kidney disease, etc., in addition to a positive ANA test before making a diagnosis of SLE. The reliability of the ANA test depends upon the laboratory Liste der Bücher zum Thema Lupus eritematoso cutâneo/terapia. Wissenschaftliche Publikationen für Bibliographien mit dem vollen PDF-Text. Die Auswahlen der Quellen und die Forschungsthemen

If SLE is clinically suspected, it is recommended to perform a follow-up test for anti-PCNA antibodies; the antigen is included in several routine ENA profiles (69) Recent studies with antigen-specific immunoassays show clinical associations also with SSc, AIM, RA, HCV, and other conditions (70-73 If ANA screening is negative, patient must be reevaluated and kept under follow-up, and test must be repeated only if clinically indicated. If ANA is negative in a patient with a high degree of clinical suspicion for SLE, ANA may be repeated. If negative again, anti-SSA antibody may assist in diagnosis of ANA-negative SLE. [4,25 Rarely, the ANA can be negative in SLE, especially in anti-Ro-antibody-positive lupus (Ro is also known as Sjogren's syndrome A or Sjogren's antibody). However, false-negative results have occurred in the past due to the use of mouse substrate in the ANA test. Now, many cell lines are transfected with Ro particles,.

Anti-nuclear antibody - Wikipedi

Presence of anti-nuclear antibodies is a risk factor for

8 ANA-negative SLE P. J. MADDISON Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that involves many different organ systems and may exhibit a wide spectrum of clinical manifestations. The protean nature of SLE means that the diagnosis of this condition depends on recognizing certain patterns of both clinical and laboratory. The presence of ANA may be associated with several autoimmune disorders, most commonly systemic lupus erythematosus (SLE). ANA includes a broad spectrum of autoantibodies including antibody to native DNA (dsDNA), Sm antigen, U1nRNP, SS-A/Ro, SS-B/La, chromatin, Scl-70, centromere, Jo-1, and several other non-histone protein or non-histone protein-RNA complexes

SLE patients, including older age at diagnosis of SLE, longer disease duration, longer duration of steroid use, and hypercholesterolemia.25,27 The overlapping inflammatory and immune-mediated nature of both SLE and atherosclerosis is being increasingly recognized, and is seen as part of the mechanistic cause of the premature CVD noted in lupus. Bij ANA-positieve auto-immuunziekte monitoring op ziekteactiviteit na vaccinatie Behandeling met anti-CD20 zoals rituximab . Ja . Ja. Als vaccinatie ingehaald kan worden: indien mogelijk >3 mnd na laatste dosis. Vaccinatie niet uitstellen indien oproep tot vaccinatie binnen dit interval van toediening Behandeling met andere biologicals . Ja . J

The antinuclear antibodies (ANA) test is the serological hallmark of SLE. Up to 98% of patients with SLE will have a positive ANA, 22 making it highly sensitive and useful as a screening test. A negative ANA makes SLE very unlikely and other diagnoses should be sought to explain symptoms. Both titre and pattern are relevant Systemische lupus erythematodes (SLE) Systemische lupus erythematodes is een reumatische bindweefselontstekingsziekte waarbij spontaan afweerstoffen ontstaan tegen delen van het eigen lichaam, zogenoemde auto-antistoffen ('auto' betekent 'zelf'). Hierdoor kunnen ontstekingen ontstaan in weefsels, zoals de huid, bindweefsel, gewrichten, de nieren, zenuwen en bloedvaten

ANA IIF is an effective screening assay in patients with clinical features of SLE and will detect most anti-ssDNA, anti-dsDNA, ENAs, and other autoantibodies. False positives are common. The clinical importance cannot be extrapolated from the ANA titre or pattern, although higher titres (> 1/160) are more likely to be important SLE can affect many parts of the body in several ways. It can range from mild to severe. There is no cure, but early treatment can help to keep symptoms under control. The rest of this information is about SLE, which we will call lupus Rarely, the ANA can be negative in SLE, especially in anti-Ro-antibody-positive lupus (Ro is also known as Sjogren's syndrome A or Sjogren's antibody). However, false-negative results have occurred in the past due to the use of mouse substrate in the ANA test • ANA negative SLE is rare More ANA Facts • ANA is not nearly as specific for SLE as it is sensitive - Autoimmune thyroid disease - Other Collagen-Vascular diseases (>90% of SSc) - Medications - Malignancies - Infections (viral) - Normal people (especially low titers) 1

Jeugdreuma e.a. - Systemische lupus erythomatosus (SLE ..

Even if you usually have mild symptoms, SLE can flare-up, with symptoms becoming more severe or new symptoms developing. Main symptoms. The 3 main symptoms of SLE are fatigue, joint pain and rashes. Fatigue. Fatigue is one of the most common symptoms of SLE The ANA test may be positive with several autoimmune disorders. Patients with the autoimmune disorder systemic lupus erythematosus (SLE) are almost always positive for ANA, but the percentage of patients with other autoimmune disorders who have positive ANA results varies Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by antibodies to nuclear and cytoplasmic antigens, multisystem inflammation, protean clinical manifestations, and a relapsing and remitting course. More than 90% of cases of SLE occur in women, frequently starting at childbearing age. See the image below

FDA Issues PPI Classwide Warning for CLE, SLESjogren's, SLE, Scleroderma - Medicine 2 with Howell atSLE grand roundNuclear with positive metaphase - University of BirminghamHEp-2: Cytoplasmic staining - University of Birmingham

Anti-Nuclear Antibody (ANA) The ANA (anti-nuclear antibody) test is a blood test that looks for antibodies that attack proteins found in the nucleus of cells.The nucleus is essentially the command centre or brain of any cell in the body. Many different types of proteins are found in the nucleus that perform many different functions A physician will order an Antinuclear Antibody (ANA) titer in order to check for autoimmune diseases. These are diseases in which the immune system in the body starts to attack the healthy cells of the host. The most common autoimmune disease that ANA titers test for is systemic lupus erythematosus (SLE). This disease is characterized.Read More.. Lupus (SLE) is a chronic, inflammatory autoimmune disorder that may affect many organ systems including the skin, joints, blood cells and internal organs, especially kidneys, and sometimes the brain.SLE affects women nine times more often than men and it usually occurs between the ages of 20-40 years although children, including newborns, and older adults can also have lupus Titers ≥ 1:160 usually indicate the presence of active SLE, although occasionally other autoimmune disease may induce these high titers. There are now known groups of ANA-negative lupus patients. Such patients often have antibodies to SS-A/Ro antigen (usually when a frozen section substrate is used) and subacute cutaneous lupus